Sanofi Gets Massachusetts Court Ruling V Rival Knee Pain Product

Sanofi (SAN) SA said a U.S. District Court in Massachusetts has granted an injunction againt a rival knee pain injection made by Seikagaku Corporation. (4548)

The ruling restricts the launch of the product ahead of a scheduled trial in April, Sanofi said in a statement.

To contact the editor responsible for this story: David Whitehouse at dwhitehouse1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.